Pfizer-BioNTech COVID-19 Vaccine Comirnaty

Staff. 2022

Overview

“Pfizer-BioNTech COVID-19 Vaccine Comirnaty (BNT162b2; Tozinameran) is an mRNA-based vaccine Approved and Authorized to prevent severe COVID-19 disease.”

Genocide by FDA and Pfizer

The FDA co-developed the approved Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) with Pfizer (Staff. 2022).

Under EUA even though no emergency exists, the FDA continually re-issues the EUA regardless of fatalities from injection. To date the shots still remain in clinical trials.